Adial Pharmaceuticals, Inc.
USD2.56
-0.03 (-1.16%)
CEO
Cary John Claiborne
IPO Date
2018-07-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.63
Prev. Close
$2.59
Day Low
$2.52
Day High
$2.69
52W Low
$1.31
52W High
$19.00
Market Cap
$0.00B
Volume
0.04M
| -1.4 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -171.5% | -147.8% | 0.00 | 4.90 | -0.4 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -388.6% | -222.1% | 0.06 | 2.67 | -0.5 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -553.7% | -254.4% | 0.07 | 2.37 | -2.6 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -272.5% | -197.8% | 0.00 | 3.41 | -2.0 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -120.3% | -111.9% | 0.00 | 14.24 | -2.8 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -261.9% | -247.5% | 0.00 | 18.19 | -2.1 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 114.2% | -3298.4% | -0.69 | 0.03 | -19.5 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | 406.0% | -277.3% | -2.26 | 0.55 | -46.1 |
| -0.8 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -39.8% | -31.7% | 0.00 | 4.34 | -1.1 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -35.0% | -28.8% | 0.00 | 5.02 | -0.4 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -104.8% | -64.6% | 0.00 | 1.99 | -1.3 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -50.9% | -41.1% | 0.00 | 4.16 | -2.3 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -37.3% | -32.7% | 0.00 | 6.78 | -0.7 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -57.5% | -49.7% | 0.00 | 5.69 | -0.5 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -105.8% | -96.9% | 0.00 | 9.48 | -0.1 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -47.0% | -40.5% | 0.00 | 4.90 | -0.4 |